Trade alert: PCRX @ 7.03

Pacira Pharmaceuticals Inc (Public, NASDAQ:PCRX) 

Key points:
- IPO on Feb/02/2011 at $7
- Raised 36m at start
- Some insider buying
- Shares authorized to issue: 250m as of Feb/08
- Shares outstanding: 17m
- Float: <41% or <7m
- FDA for EXPAREL in third quarter of 2011 (july/28/2011), the company's most advanced investigational product candidate.
- Pacira plans to commercialize EXPAREL in the U.S. in the fourth quarter of 2011.

Current pps: $7.03
Link to chart: link
Link to google finance: link
Link to latest headlines: link
Company website: link
Analyst ratings: link

*Please do your own research before buying any stock listed here. Read disclaimer.

>> Subscribe to our posts.